Over at Forbes' The Science Business blog, Matthew Herper reports on Life Technologies' $100 million investment in synthetic biology — including its recent acquisition of a majority stake in Geneart, and an equity investment i
Registering provides access to this and other free content.
Already have an account?Login Now.
Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.
The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.
The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.
In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.